CCR3: Early detection and treatment of wet macular degeneration will be facilitated in the future
News CCR3 - New therapeutic approach in the early stages of wet macular degeneration
A New Target for Neovascular AMD
Since the middle of the last decade, pharmacotherapy has transformed the management of neovascular age-related macular degeneration (AMD). Specifically, the ability to pharmacologically inhibit vascular endothelial growth factor (VEGF) has changed the prognosis of neovascular AMD from one of laser photocoagulation and observation of progressively worsening vision to the current paradigm of stabilization or improvement of vision for most patients with repeated intravitreal injections of an anti-VEGF agent.
CCR3: Shedding New Light on a Dark Problem?
A recent work by Ambati et al. represents a bold step towards a more effective diagnosis and treatment of age-related macular degeneration, with the new evidence showing that CCR3, a chemokine receptor, is an early marker of and potential therapeutic target for choroidal neovascularization development.
UK leads on eye disease discoveries
Discoveries by University of Kentucky researchers potentially could lead to a new way of simultaneously detecting and treating a type of macular degeneration
Nowe spojrzenie na poważną chorobę oczu
Receptor o nazwie CCR3 jest odpowiedzialny za rozwój związanego z wiekiem zwyrodnienia plamki żółtej i może stanowić dobry marker diagnostyczny tej choroby
La Stampa 16.06.2009
Nuove possibilità nella diagnosi e cura della degenerazione maculare
Bloccare una proteina per ridurre la crescita anormale dei vasi sanguigni
Breakthrough In Early Detection And Prevention Of Age-related Macular Degeneration
Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration
Age-Related Macular Degeneration Halted by Blocking Protein to Stop Blood Vessel Growth
Protein CCR3 a new target for diagnosis and treatment of AMD, the most common cause of blindness in senior citizens.
Major Breakthrough in Early Detection and Prevention of AMD
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.
Identifican una diana terapéutica para la ceguera asociada a la edad
Investigadores de la Universidad de Kentucky en Lexington (Estados Unidos) han identificado un posible marcador para detectar la degeneración macular asociada a la edad (DMAE)
Study suggests new approach to common cause of blindness
Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration, the most common cause of blindness in older Americans.
Presse Früherkennung und Therapie der feuchten Makuladegeneration zukünftig erleichtert